4
Changes in Ownership
Aptevo Therapeutics Inc. Filed Acc 0001209191-22-045183
Options or other derivatives
- CFO acquired 34,958 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Lamothe Jeffrey G. CFO | 2022-08-09 | Grant or award · Restricted Stock Unit | +5,500 | 5,500 | D | ||
| Lamothe Jeffrey G. CFO | 2022-08-09 | Grant or award · Stock Option (right to buy) | +5,500 | 5,500 | D | ||
| Lamothe Jeffrey G. CFO | 2022-08-09 | Grant or award · Restricted Stock Unit | +23,958 | 23,958 | D | ||
Loading xslF345X03/doc4.xml…